Deal snapshot: Germany's Merck KGaA to Acquire US Contract Manufacturer Exelead.

MANews-(C)2009-2022

Germany-based science and technology company Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire US-based biopharmaceutical contract development and manufacturing organization Exelead for approximately USD 780m in cash, the company said.

Exelead specializes in complex injectable formulations...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT